Selectis Health annual stock-based compensation
2011
2013
2014
2015
2018
2019
2020
2021
2022
2023
2024
Selectis Health Stock-Based Compensation Growth & History (GBCS)
Selectis Health's stock-based compensation was $0 for fiscal 2024.
View full Selectis Health company overviewSelectis Health annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $0 | −$624 | — |
| 2023 | 2023-12-31 | $624 | $624 | — |
| 2022 | 2022-12-31 | $0 | −$18,650 | — |
| 2021 | 2021-12-31 | $18,650 | $27,400 | — |
| 2020 | 2020-12-31 | −$8,750 | −$288,837 | — |
| 2019 | 2019-12-31 | $280,087 | $145,087 | +107.47% |
| 2018 | 2018-12-31 | $135,000 | — | — |
| 2015 | 2015-12-31 | $179,999 | $132,651 | +280.16% |
| 2014 | 2014-12-31 | $47,348 | — | — |
| 2013 · Jun 30 | 2013-06-30 | $83,300 | — | — |
| 2011 | 2011-06-30 | $32,500 | — | — |
Selectis Health quarterly stock-based compensation
Q2.14
Q3.14
Q1.18
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q4.19
Q3.20
Q3.21
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q3 2021 | 2021-09-30 | $0 | $0 | — |
| Q3 2020 | 2020-09-30 | $0 | −$79,155 | — |
| Q4 2019 | 2019-12-31 | $25,953 | — | — |
| Q3 2019 | 2019-09-30 | $79,155 | $34,155 | +75.90% |
| Q2 2019 | 2019-06-30 | $124,450 | $12,250 | +10.92% |
| Q1 2019 | 2019-03-31 | $50,529 | $5,529 | +12.29% |
| Q3 2018 | 2018-09-30 | $45,000 | — | — |
| Q2 2018 | 2018-06-30 | $112,200 | — | — |
| Q1 2018 | 2018-03-31 | $45,000 | — | — |
| Q3 2014 | 2014-09-30 | $47,348 | — | — |
| Q2 2014 | 2014-06-30 | $47,348 | — | — |
Selectis Health stock-based compensation trends
Over the last five fiscal years, Selectis Health's stock-based compensation decreased from $280,087 to $0, a change of −$280,087. The latest reported quarter, Q3 2021, shows $0.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Selectis Health source filings ↗